Eli Lilly and Company
LLY
$1,189.41
-$44.25-3.59%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 7.10B | 7.40B | 6.64B | 5.58B | 5.66B |
| Total Depreciation and Amortization | 534.00M | 509.00M | 585.70M | 470.00M | 478.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.73B | -908.00M | -324.70M | 1.58B | -789.00M |
| Change in Net Operating Assets | -670.00M | -1.66B | -3.67B | 1.21B | -2.26B |
| Cash from Operations | 10.69B | 5.33B | 3.22B | 8.84B | 3.09B |
| Capital Expenditure | -2.93B | -2.33B | -2.55B | -2.09B | -1.70B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -8.75B | -1.06B | -111.60M | -549.40M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.72B | -532.00M | -143.90M | -345.50M | -137.00M |
| Cash from Investing | -15.40B | -3.92B | -2.80B | -2.98B | -1.83B |
| Total Debt Issued | 12.45B | 1.78B | -200.00K | 6.71B | 0.00 |
| Total Debt Repaid | -873.00M | -750.00M | -300.00K | -4.09B | 825.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -1.60B | -2.36B | -1.51B | -708.10M | -692.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.55B | -1.55B | -1.35B | -1.35B | -1.35B |
| Other Financing Activities | -4.00M | -591.00M | -25.10M | -30.20M | -31.00M |
| Cash from Financing | 8.43B | -3.47B | -2.88B | 531.00M | -1.25B |
| Foreign Exchange rate Adjustments | -52.00M | 67.00M | -67.10M | 31.70M | 275.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.67B | -1.99B | -2.52B | 6.42B | 283.00M |